BIOCON vs GRANULES: Stock Comparison

Biocon Limited vs Granules India Limited

Live data: 22 July 2026, 3:00 PM IST • Source: NSE and company filings

Biocon Limited is the larger company by market capitalisation. Granules India Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Biocon Limited and Granules India Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BIOCON is more favourable on 1 of 13 scored metrics and GRANULES on 12These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BIOCON is the larger company
₹70,989 Cr vs ₹21,049 Cr
P/E Ratio
GRANULES has a lower P/E
36.28x vs 185.25x
P/B Ratio
BIOCON has a lower P/B
2.1x vs 4.24x
EPS
GRANULES has higher earnings per share
₹24.44 vs ₹2.86
Dividend Yield
GRANULES has a higher dividend yield
0.2% vs 0.11%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 2.3%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs -72.5%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
22.8% vs 2.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBIOCONGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBIOCONGRANULES
Live Price₹437.25₹853.55
Day Change-0.69%-2.53%
Volume51.42 L14.38 L
52-Week High₹447.15₹910
52-Week Low₹331₹432.6
Distance from 52W High-2.21%-6.2%

Valuation

MetricBIOCONGRANULES
Market Cap₹70,989 Cr₹21,049 Cr
P/E Ratio185.25x36.28x
P/B Ratio2.1x4.24x
EPS₹2.86₹24.44
Book Value₹210.14₹205.21
Dividend Yield0.11%0.2%

Growth

MetricBIOCONGRANULES
Revenue Growth (TTM YoY)2.3%22.8%
EPS Growth (TTM YoY)-72.5%31.3%
Qtr Sales Growth2.25%22.8%
Qtr Profit Growth-62%44.6%

Profitability & Leverage

MetricBIOCONGRANULES
ROE1.4%13.7%
ROCE3.75%15.5%
Net Margin2.29%11.15%
Operating Margin20.4%22.1%
Debt to Equity0.45x0.3x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBIOCONGRANULES
Promoter Holding29.73% 0.17 pp37.67%
FII Holding8.16% 0.64 pp17.5% 2.19 pp
DII Holding23.37% 0.7 pp16.11% 0.9 pp
Public Holding23.74% 0.33 pp28.38% 1.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Biocon Limited and Granules India Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.